Ellie Murrow
Analyst
Barclays
Equibles does not estimate personal net worth.
About Ellie Murrow
Ellie Murrow is recorded as Analyst at Barclays. Ellie Murrow has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Sarepta Therapeutics, Inc. on August 5, 2026. Those appearances were for Sarepta Therapeutics, Inc. (SRPT), MBX Biosciences, Inc. (MBX) and REGENXBIO Inc. (RGNX). The companies whose calls Ellie Murrow spoke on are classified in the Healthcare sector.
Ellie Murrow on recent calls
“Just a clarification on some of your Elevitus commentary. You mentioned you saw a quarter-over-quarter increase in Elevitus enrollment forms. Just to clarify, are you also seeing an increase in start forms in 3Q versus 2Q, or if you could just characterize that trajectory?”
“Thanks so much for joining us here in Miami for the Barclays 20th Annual Global Healthcare Conference. Very happy to have MBX here with us today. I'm Ellie Murrow, one of the biotech analysts here at Barclays.”
“I think you mentioned you expect 12-month functional data from the majority, if not all, of the pivotal patients in the fall of this year. So, how should we think of those data in context of the regulatory strategy?”
Affiliation history
-
Barclays
Analyst
Transcript header (unverified)
Current
Company network
REGENXBIO Inc.
RGNX
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-05
View calls and events